Centrient Pharmaceuticals
Ronald Merckx has extensive work experience in finance and leadership roles. Ronald is currently the Chief Financial Officer at Centrient Pharmaceuticals since 2019. Prior to this, they worked as the Chief Financial Officer at Royal Wessanen nv from 2011 to 2019. At Britax Childcare, they served as the Finance Director - Europe from 2007 to 2011. Before that, they held various finance positions at Unilever from 1991 to 1997. Ronald also served as the Finance Director - Langnese Iglo GmbH Germany, Vice-President Finance - ICFE Business Group, Corporate Controller - Lever Faberge, and Investor Relations Manager at Unilever from 1998 to 2007.
Ronald Merckx obtained their Drs degree in Economics from Universiteit van Tilburg in the period from 1985 to 1991. Ronald then pursued a Chartered Accountant program at the same university from 1991 to 1992, earning the RA qualification. No recorded information is available regarding their education at Clariden.
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.